- $100.09m
- $267.64m
- $278.30m
- 37
- 58
- 46
- 44
Annual balance sheet for Cardlytics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 293 | 233 | 122 | 91.8 | 65.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 86.6 | 117 | 120 | 126 | 107 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 386 | 359 | 250 | 224 | 178 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 24.6 | 21.5 | 12.5 | 10.6 | 8.94 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 423 | 1,264 | 691 | 574 | 393 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 81.3 | 327 | 249 | 171 | 149 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 265 | 573 | 480 | 439 | 323 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 157 | 691 | 212 | 135 | 70 |
| Total Liabilities & Shareholders' Equity | 423 | 1,264 | 691 | 574 | 393 |
| Total Common Shares Outstanding |